Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

A Public Health Approach to Arthritis: Experts Continue to Raise Awareness of Arthritis Burden

Thomas R. Collins  |  February 12, 2020

ATLANTA—Rheumatic diseases have been the subject of a range of public health campaigns and reports over the past decade, but improving their visibility remains a work in progress, a Centers for Disease Control and Prevention (CDC) expert said at the 2019 ACR/ARP Annual Meeting. A growing attention to pain and the opioid crisis may help in this regard, he said.

Charles (Chad) Helmick, MD, a medical epidemiologist and the scientific lead for the CDC’s arthritis program, said the organization, in collaboration with many other groups and universities, is continuing in its push.

Charles Helmick, MD

“The overriding issue in my mind is the need for greater visibility for arthritis and other rheumatic conditions as important health problems,” he said.

When Dr. Helmick created the CDC’s arthritis program in 1999, he was cautioned about the challenge that lay ahead of him, mainly because rheumatic conditions are not among the major, deadly diseases, such as cancer and cardiovascular disease, that occupy so much space in the public consciousness.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“‘This is not a fatal disease—you’re sort of leading the way for a lot of other chronic, non-fatal disabling diseases,’” he recalled being told. “And it’s tough. We’ve worked on it, and I think we’ve done a lot of successful things over that time.”

Burden of Rheumatic Conditions
The burden of rheumatic conditions continues to be great in the U.S. According to CDC reports covering 2013–15, 54 million adults, or 22.7% of the adult population, had arthritis, and 22.7 million adults, or 43.5%, had limitations to activity they attributed to arthritis.1 By 2040, the CDC’s National Health Interview Survey predicts 78 million adults will have arthritis, and that is almost certainly an underestimate because it counts only the change based on the population structure by age, Dr. Helmick said.

“It does not take into account the obesity epidemic, which I think will make this number even higher,” he cautioned.

In 2013, the cost attributed to arthritis was $304 billion—$140 billion in medical costs and $164 billion in lost earnings. That’s equal to $2,117 in medical costs per adult with arthritis, and $4,040 less in pay for an adult with arthritis vs. an adult without arthritis.2

In an assessment of adults with arthritis across the states, a median of 30.3% had severe joint pain, with Colorado having the lowest percentage at 20.8% and Mississippi the highest at 45.2%.3

A Major Cause of Disability
Research has found the main causes of disability among adults in the U.S. are arthritis or rheumatism, just ahead of back or spine problems.4 “They were way ahead of some of the other big things, like heart disease and diabetes and mental health problems,” Dr. Helmick said.

Page: 1 2 3 | Single Page
Share: 

Filed under:Professional Topics Tagged with:ArthritisburdenCDCpublic health

Related Articles

    A Public Health Approach to Arthritis

    March 12, 2020

    ATLANTA—Rheumatic diseases have been the subject of a range of public health campaigns and reports over the past decade, but improving their visibility remains a work in progress, a Centers for Disease Control and Prevention (CDC) expert said at the 2019 ACR/ARP Annual Meeting. A growing attention to pain and the opioid crisis may help…

    Late Summer 2022’s Awards, Appointments & Announcements in Rheumatology

    August 14, 2022

    Charles G. Helmick III, MD, Retires After 42 Years with the CDC On Dec. 31, 2021, after 42 years of service, Charles (Chad) G. Helmick III, MD (Capt., USPHS, Ret.), officially retired from the Centers for Disease Control and Prevention. He joined the CDC in 1979, when Jimmy Carter was president, and served through eight…

    The 2018 ARHP Merit Awards & ACR Distinguished Fellows

    December 18, 2018

    CHICAGO—At the 2018 ACR/ARHP Annual Meeting in October, the ACR and the ARHP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist speaks with the winners of the ARHP Merit Awards about their individual contributions to advancing rheumatology. You’ll also find interviews…

    The 2022 ARP President’s & Merit Awards

    November 6, 2022

    During ACR Convergence 2022 in early November, the ACR and the ARP honored a group of distinguished individuals who have made significant contributions to rheumatology research, education and patient care. This month, The Rheumatologist profiles the recipients of the ARP President’s and Merit Awards. ARP PRESIDENT’S AWARDS The ARP president can choose to honor ACR/ARP…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences